HSBC Holdings’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

HSBC Holdings’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,653	Closed	-$201K	–	2314
2015 Q3	$201K	Buy	+4,653	New	+$196K	﹤0.01%	1804

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

HSBC Holdings's WX Position: Q4 2015 in Review

HSBC Holdings sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 4,653 shares — an estimated $201K sold.

HSBC Holdings first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $201K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

HSBC Holdings reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
HSBC Holdings sold 4,653 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $201K.
HSBC Holdings first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
HSBC Holdings's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $201K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on HSBC Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.